Opko Pharmaceuticals, LLC

FL · United States · Reporting entity ID 100000151639

Total reported 2019–2025

$10.6M

#474 of 2,960 reporting companies — 0% of all reported industry payments

$1.45M in general payments across 47,034 records, plus $9.16M in research funding across 683 records.

How it breaks down

General payments $1,446,515

Research funding $9,161,653

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.